Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
The British Journal of Diabetes & Vascular Disease
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Bailey, C. J
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

The Diabetes Prevention Program: headline results

Clifford J Bailey

Diabetes Group, School of Pharmacy, Aston University, Birmingham, B4 7ET, c.j.bailey{at}aston.ac.uk

The Diabetes Prevention Program (DPP) was a trial of over 3,000 people with impaired glucose tolerance (IGT) to assess the effect of different interventions on their progression to type 2 diabetes. During an average follow-up period of three years, intensive lifestyle intervention with regular exercise and weight loss reduced the risk of progression to type 2 diabetes by 58%. Treatment with the antihyperglycaemic agent metformin reduced progression to type 2 diabetes by 31%. The DPP has therefore confirmed that rigorous lifestyle management can reduce the risk of type 2 diabetes and also shown that metformin therapy can reduce diabetes risk.

The British Journal of Diabetes & Vascular Disease, Vol. 1, No. 1, 62-64 (2001)
DOI: 10.1177/14746514010010011001
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 British Journal of Diabetes & Vascular DiseaseHome page
L. S. Hermann and N. Wiernsperger
Impaired glucose tolerance and metformin: clinical and mechanistic aspects
The British Journal of Diabetes & Vascular Disease, May 1, 2002; 2(3): 177 - 183.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
N. Goenka, K. Marwa, H. S Randeva, J. Morrissey, and V. Patel
Diabetes care in the Sikh patient: cultural and clinical aspects
The British Journal of Diabetes & Vascular Disease, May 1, 2002; 2(3): 202 - 205.
[PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
J. D Mills and P. J Grant
Insulin resistance, haemostatic factors and cardiovascular risk
The British Journal of Diabetes & Vascular Disease, January 1, 2002; 2(1): 19 - 26.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
V. Patel and J. Morrissey
The Alphabet Strategy: The ABC of reducing diabetes complications
The British Journal of Diabetes & Vascular Disease, January 1, 2002; 2(1): 58 - 59.
[Abstract] [PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
M. J Davies
A National Service Framework for diabetes
The British Journal of Diabetes & Vascular Disease, November 1, 2001; 1(2): 123 - 125.
[PDF]

Home page
 British Journal of Diabetes & Vascular DiseaseHome page
V. Patel, J. Morrissey, N. Goenka, D. James, and S. Shaikh
Diabetes care in the Hindu patient: cultural and clinical aspects
The British Journal of Diabetes & Vascular Disease, November 1, 2001; 1(2): 132 - 135.
[PDF]